This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
“compound 4j” (Janssen (JNJ) brain-penetrant in vivo 5-HT2 antagonist and 5-HT7 inverse agonist, backup candidate)
molecule
2 years ago ●
1 min read
October’s molecule, the Bayer hGnRH-R antagonist BAY 1214784, is intended as an oral, once-daily treatment for uterine fibroids, a highly common problem…
molecule
2 years ago ●
1 min read
BAY 1217224 (Bayer oral non-prodrug thrombin (Factor IIa) inhibitor)
molecule
2 years ago ●
1 min read
CC-90011 (Celgene/Bristol Myers Squibb (BMS)) selective, reversible LSD1 inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
LEO 39652 (LEO Pharma “dual-soft” topical PDE4 inhibitor soft drug clinical candidate)
molecule
2 years ago ●
1 min read
OATD-01 (OncoArendi Therapeutics oral, first-in-class CHIT1/AMCase chitinase inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
Load More
